David Bearss

Company: Halia Therapeutics

Job title: Chief Executive Officer, President & Chairman Of The Board

Seminars:

Panel Discussion: Uncovering the Tangible Translation of Biomarkers for Therapeutic Effectiveness & Target Engagement 1:00 pm

Discussing the current state of play in inflammasome biomarkers to understand the landscape and missing pieces Debating where to go next for inflammasome biomarker strategies and clinical development considerationsRead more

day: day 1 post lunch track 2